Filing Details
- Accession Number:
- 0001203311-22-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-09 19:02:45
- Reporting Period:
- 2022-02-07
- Accepted Time:
- 2022-02-09 19:02:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-07 | 100 | $26.10 | 668,045 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-07 | 100 | $137.29 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-07 | 3,574 | $26.10 | 671,519 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-07 | 3,574 | $138.97 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-07 | 8,985 | $26.10 | 676,930 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-07 | 8,985 | $139.96 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-07 | 4,084 | $26.10 | 672,029 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-07 | 4,084 | $140.83 | 667,945 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-02-07 | 300 | $26.10 | 668,245 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-07 | 300 | $141.56 | 667,945 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-02-07 | 100 | $0.00 | 100 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-02-07 | 3,574 | $0.00 | 3,574 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-02-07 | 8,985 | $0.00 | 8,985 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-02-07 | 4,084 | $0.00 | 4,084 | $26.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-02-07 | 300 | $0.00 | 300 | $26.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 119,201 | 2022-08-20 | No | 4 | M | Direct | |
| 115,627 | 2022-08-20 | No | 4 | M | Direct | |
| 106,642 | 2022-08-20 | No | 4 | M | Direct | |
| 102,558 | 2022-08-20 | No | 4 | M | Direct | |
| 102,258 | 2022-08-20 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $138.36 to $139.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $139.36 to $140.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $140.36 to $141.32. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $141.40 to $141.78. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16.
Billionaire Hedge Funds
